Pancreatic cancer is a rare disease; however, its initially inconspicuous symptoms and aggressive nature make it one of the ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

Dr. Benjamin Jon Golas of Hackensack Meridian Health discussed the main strategies for treating pancreas cancer, focusing on ...

Pancreatic Cancer Action Network Calls for Immediate, Sustained Investment in Research Toward Early Detection and Treatment ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

SAN FRANCISCO -- Almost 80% of patients with heavily pretreated advanced/metastatic pancreatic cancer achieved disease ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic ...